Primary regulatory
USP General Chapter <797>: Pharmaceutical Compounding: Sterile Preparations
USP <797> establishes standards for sterile compounding including the use of bacteriostatic water for injection in multi-dose preparations, beyond-use dating, and storage requirements for reconstituted products.
United States Pharmacopeia (USP)Published 2023-11-01Accessed 2026-07-08
Registry record
Source metadata
- Publisher
- United States Pharmacopeia (USP)
- Source type
- Primary regulatory
- Registry ID
usp-797-sterile-compounding
Source usage
Linked from 9 pages
Guide
Bacteriostatic Water Guide: What It Is, How It Differs From Sterile Water, and Why It Matters for Peptide Reconstitution
GuideBest Pen Case for Peptides: What to Look For
GuideBest Peptide Travel Case: What to Look For
GuideCompounded GLP-1 Regulation: What Changed and What to Check
GuidePeptide Storage Guide: Lyophilized, Reconstituted, and Degradation
GuidePeptide Supplies Directory: What Researchers Use
GuidePeptide Terminology Glossary
GuideState-by-State Peptide Regulation: Research Chemicals, Compounding, Syringes, and Telehealth Prescribing
GuideSterile vs Bacteriostatic Water: What Changes After the Seal Is Broken
Interpretation boundary
What this record can and cannot establish
Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.